News Releases

Orgenesis Approved for EUR 2.015.000 Grant to Support Development of its Type 1 Diabetes Program in Europe
Nov 24, 2014

Orgenesis Receives Patent for Potential Cure for Type 1 Diabetes
Oct 15, 2014

Scott Carmer Named as CEO of Orgenesis North America
Aug 05, 2014

Orgenesis Signs Agreement With MaSTherCell to Scale Manufacturing of Insulin-Producing Liver Cells to Combat Diabetes
Jul 07, 2014

Orgenesis Awarded Maryland Stem Cell Research Fund Grant
May 29, 2014

Orgenesis Secures $3 Million in Funding from Kodiak Capital Group
Dec 17, 2013

Orgenesis CSO & Founder, Dr. Sarah Ferber, to Present at the 2013 World Stem Cell Summit on December 4
Dec 03, 2013

Orgenesis Establishes Belgium Subsidiary for Manufacturing Process Development of Clinical Grade Cells
Nov 05, 2013

Orgenesis Engages Liolios Group to Lead New Investor Relations Program
Oct 03, 2013

Orgenesis to Present at the 2013 Gateway Conference on September 10
Sep 04, 2013



RSS Feed

icon-rss Preview or subscribe to our news feed here.


Historical Press Releases

This website contains historical and archived press releases for Orgenesis Inc. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Orgenesis Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

Back to Top